Page 6 - Haematologica - Vol. 105 n. 6 - June 2020

haematologica Journal of the Ferrata Storti Foundation
1539 Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia Nabih Maslah et al.
Acute Myeloid Leukemia
1552 The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial Friedrich Stölzel et al.
1559 Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism
Luca Mazzarella et al.
Myeloid Neoplasms
1567 Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders Farhad Ravandi et al.
Acute Lymphoblastic Leukemia
1575 Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia Aurore Touzart et al.
Non-Hodgkin Lymphoma
1582 Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay Fanny Drieux et al.
1593 The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T cells William Townsend et al.
1604 KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
Simone Ferrero et al.
Chronic Lymphocytic Leukemia
1613 A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia Jared A. Cohen et al.
1621 IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study
Emelie Curovic Rotbain et al.
Plasma Cell Disorders
1630 Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy Jia Tong et al.
1641 Identification of PIKfyve kinase as a target in multiple myeloma Cecilia Bonolo de Campos et al.
1650 Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Lene Kongsgaard Nielsen et al.
Platelet Biology & its Disorders
1660 Glycoprotein Ib clustering in platelets can be inhibited by α-linolenic acid as revealed by cryo-electron tomography Simona Stivala et al.
1667 Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse platelets Inga Scheller et al.
Myelodysplastic Syndromes
Haematologica 2020; vol. 105 no. 6 - June 2020 http://www.haematologica.org/